Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 5
Submit an article Journal homepage
612
Views
11
CrossRef citations to date
0
Altmetric
Author's View

Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease

Anandi Sawant Department of Pathology; University of Alabama at Birmingham; Birmingham, AL USA
&
Selvarangan Ponnazhagan Department of Pathology; University of Alabama at Birmingham; Birmingham, AL USACorrespondence[email protected]
Article: e24064 | Received 13 Feb 2013, Accepted 21 Feb 2013, Published online: 01 May 2013

References

  • Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253 - 68; http://dx.doi.org/10.1038/nri3175; PMID: 22437938
  • Almand B, Clark JI, Nikitina E, van Beynen J, English NR, Knight SC, et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 2001; 166:678 - 89; PMID: 11123353
  • Sawant A, Deshane J, Jules J, Lee CM, Harris BA, Feng X, et al. Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer. Cancer Res 2013; 73:672 - 82; http://dx.doi.org/10.1158/0008-5472.CAN-12-2202; PMID: 23243021
  • Danilin S, Merkel AR, Johnson JR, Johnson RW, Edwards JR, Sterling JA. Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction. Oncoimmunology 2012; 1:1484 - 94; http://dx.doi.org/10.4161/onci.21990; PMID: 23264895
  • Zhuang J, Zhang J, Lwin ST, Edwards JR, Edwards CM, Mundy GR, et al. Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells. PLoS One 2012; 7:e48871; http://dx.doi.org/10.1371/journal.pone.0048871; PMID: 23173040
  • Charles JF, Hsu LY, Niemi EC, Weiss A, Aliprantis AO, Nakamura MC. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. J Clin Invest 2012; 122:4592 - 605; http://dx.doi.org/10.1172/JCI60920; PMID: 23114597
  • Das S, Samant RS, Shevde LA. Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis. J Biol Chem 2011; 286:9612 - 22; http://dx.doi.org/10.1074/jbc.M110.174920; PMID: 21169638
  • Raje N, Roodman GD. Advances in the biology and treatment of bone disease in multiple myeloma. Clin Cancer Res 2011; 17:1278 - 86; http://dx.doi.org/10.1158/1078-0432.CCR-10-1804; PMID: 21411443
  • Sawant A, Hensel JA, Chanda D, Harris BA, Siegal GP, Maheshwari A, et al. Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells. J Immunol 2012; 189:4258 - 65; http://dx.doi.org/10.4049/jimmunol.1101855; PMID: 23018462
  • Chauhan D, Singh AV, Brahmandam M, Carrasco R, Bandi M, Hideshima T, et al. Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target. Cancer Cell 2009; 16:309 - 23; http://dx.doi.org/10.1016/j.ccr.2009.08.019; PMID: 19800576

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.